Economy
2 شهرين، 2 أسبوعين منذ
Stock Market Today, March 26: Wave Life Sciences Plunges After High Dose Obesity Drug Data Disappoints
On March 26, 2026, traders mulled Wave's weak high-dose obesity results against the company's large market opportunity.
التأثير على WVE:
The disappointing data from Wave Life Sciences' high-dose obesity drug trial is …
Wave Life Sciences' high-dose obesity drug data disappoints, leading to a plunge in its stock …
الأعلى (80%)
عرض التحليل الكامل →